Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Jul 2012

Wu Chen Hsuan, Mao Tsui-Lien, Vang Russell, Ayhan Ayse, Wang Tian-Li, Kurman Robert J, Shih Ie-Ming

Abstract excerpt

Nongastrointestinal-type mucinous borderline tumors have been described as displaying endocervical and serous differentiation and hence have been termed "endocervical-type" mucinous borderline tumors, "mixed-epithelial papillary cystadenoma of borderline malignancy of mullerian type," or "atypical proliferative seromucinous tumors." A striking feature of these tumors is their frequent association with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Endometrioid
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Genes, Tumor Suppressor

Share to Immunohistochemistry

Share to Nuclear Proteins

Share to Ovarian Neoplasms

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 22653341
DOI: 10.1097/PGP.0b013e31823f8482
PMCID: PMC3501990

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.PMID 22653341Read ↗

Seromucinous Tumors of the Ovary. What's in a Name?Semantic proximity Read ↗

ARID1A is a useful marker of malignancy in peritoneal washings for endometrial carcinoma.Semantic proximity Read ↗

Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.Semantic proximity Read ↗

Endometrioid Versus Seromucinous Borderline Ovarian Tumors: Divergent Molecular Signatures and a Shared Role as Precursors to Endometrioid Carcinoma.Semantic proximity Read ↗

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma.Semantic proximity Read ↗

Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.Semantic proximity Read ↗

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.Semantic proximity Read ↗

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian CarcinomasSemantic proximity Read ↗

Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian CancersSemantic proximity Read ↗

ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis.Semantic proximity Read ↗

Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive.Semantic proximity Read ↗

The emerging roles of ARID1A in tumor suppression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.